Which components are included in the initial management of IRDS/HMD?

Prepare for the Registered Respiratory Therapist CSE with comprehensive flashcards and multiple-choice questions, including hints and explanations. Ace your exam with confidence!

Multiple Choice

Which components are included in the initial management of IRDS/HMD?

Managing IRDS/HMD starts with supporting oxygenation and lung mechanics while keeping the baby warm and reducing extra stress on the body. Providing oxygen along with noninvasive CPAP (4–6 cmH2O) helps keep alveoli open, improves lung recruitment, and lowers the work of breathing. Setting a target for oxygenation, such as PaO2 around 50–80 mmHg and SpO2 about 89–90%, helps avoid both hypoxemia and the risks of hyperoxia. A neutral thermal environment minimizes heat loss and metabolic demand, which helps with overall oxygen use. Surfactant therapy addresses the underlying deficiency—surfactant is crucial for reducing surface tension and improving lung compliance, gas exchange, and stability of the alveoli. If needed, escalating to mechanical ventilation with PEEP preserves alveolar recruitment and supports ongoing gas exchange. Oxygen therapy by itself won’t prevent alveolar collapse or treat the surfactant deficiency; avoiding CPAP removes an important means of maintaining lung openness; and providing no respiratory support at all ignores the critical need to stabilize oxygenation and lung function in this condition.

Managing IRDS/HMD starts with supporting oxygenation and lung mechanics while keeping the baby warm and reducing extra stress on the body. Providing oxygen along with noninvasive CPAP (4–6 cmH2O) helps keep alveoli open, improves lung recruitment, and lowers the work of breathing. Setting a target for oxygenation, such as PaO2 around 50–80 mmHg and SpO2 about 89–90%, helps avoid both hypoxemia and the risks of hyperoxia. A neutral thermal environment minimizes heat loss and metabolic demand, which helps with overall oxygen use. Surfactant therapy addresses the underlying deficiency—surfactant is crucial for reducing surface tension and improving lung compliance, gas exchange, and stability of the alveoli. If needed, escalating to mechanical ventilation with PEEP preserves alveolar recruitment and supports ongoing gas exchange.

Oxygen therapy by itself won’t prevent alveolar collapse or treat the surfactant deficiency; avoiding CPAP removes an important means of maintaining lung openness; and providing no respiratory support at all ignores the critical need to stabilize oxygenation and lung function in this condition.

More practice questions